Equity Overview
Price & Market Data
Price: $3.17
Daily Change: -$0.185 / 5.85%
Range: $3.13 - $3.55
Market Cap: $119,222,704
Volume: 46,111
Performance Metrics
1 Week: -6.76%
1 Month: -19.34%
3 Months: -51.60%
6 Months: -55.16%
1 Year: -68.17%
YTD: -61.06%
Company Details
Employees: 64
Sector: Health services
Industry: Medical/Nursing services
Country: United States
Details
Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman for the prediction of the expectant mother's risk of delivering spontaneously. It is also developing a pipeline of novel blood-based biomarker tests for major pregnancy-related conditions, including time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.